Home » Topics » BioWorld Science

BioWorld Science
RSS

First-in-human data for RZ-402 show potential for once-daily dosing

May 6, 2021

AbCellera and Eli Lilly present second antibody to enter clinical development against COVID-19

May 6, 2021

First-in-human trial evaluates RPTR-168 in HPV-16 E6/E7-positive tumors and melanoma

May 6, 2021

Triumvira initiates phase I/II trial of TAC-01-HER2 in relapsed or refractory solid tumors

May 6, 2021

Tecentriq approved in E.U. for first-line metastatic NSCLC with high PD-L1 expression

May 5, 2021

SOM-3355 reduces chorea in patients with HD

May 5, 2021

Preclinical characterization of novel small molecule inhibitor of CD38, RBN-013209

May 5, 2021

European Commission approves Sibnayal for distal renal tubular acidosis

May 5, 2021

FDA clears IND for phase I/II study of Clarity's prostate cancer theranostic products

May 5, 2021

Ascletis reports phase IIa data on ASC-22 for chronic hepatitis B

May 5, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...